{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:02:45Z","timestamp":1789909365973,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1007\/s11938-003-0045-2","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T19:11:24Z","timestamp":1180897884000},"page":"427-441","source":"Crossref","is-referenced-by-count":19,"title":["Treatment of gastrointestinal problems in cystic fibrosis"],"prefix":"10.1007","volume":"6","author":[{"given":"Maria R.","family":"Mascarenhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"45_CR1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/j.1572-0241.2000.02244.x","volume":"95","author":"RC Stern","year":"2000","unstructured":"Stern RC, Eisenberg JD, Wagener JS, et al.: A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000, 95:1932\u20131938.","journal-title":"Am J Gastroenterol"},{"key":"45_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1651-2227.1995.tb13699.x","volume":"84","author":"L Millar-Jones","year":"1995","unstructured":"Millar-Jones L, Goodchild MC: Cystic fibrosis, pancreatic sufficiency and distal intestinal obstruction syndrome: a report of four cases. Acta Paediatr 1995, 84:577\u2013578.","journal-title":"Acta Paediatr"},{"key":"45_CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/9635","volume":"2","author":"J Zielenski","year":"1999","unstructured":"Zielenski J, Corey M, Rozmahel R, et al.: Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 1999, 2:128\u2013129.","journal-title":"Nat Genet"},{"key":"45_CR4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0022-3468(99)90110-0","volume":"34","author":"RK Minkes","year":"1999","unstructured":"Minkes RK, Langer JC, Skinner MA, et al.: Intestinal obstruction after lung transplantation in children with cystic fibrosis. J Pediatr Surg 1999, 34:1489\u20131493.","journal-title":"J Pediatr Surg"},{"key":"45_CR5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0022-3468(90)90186-D","volume":"25","author":"JP Coughlin","year":"1990","unstructured":"Coughlin JP, Gauderer MW, Stern RC, et al.: The spectrum of appendiceal disease in cystic fibrosis. J Pediatr Surg 1990, 25:835\u2013839.","journal-title":"J Pediatr Surg"},{"key":"45_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000658-199202000-00014","volume":"215","author":"CA Pin Del","year":"1992","unstructured":"Del Pin CA, Czyrko C, Ziegler MM, et al.: Management and survival of meconium ileus\u2014a 30-year review. Ann Surg 1992, 215:179\u2013185.","journal-title":"Ann Surg"},{"key":"45_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00005176-199911000-00029","volume":"29","author":"SS Baker","year":"1999","unstructured":"Baker SS, Liptak GS, Colletti RB, et al.: Constipation in infants and children: evaluation and treatment. J Pediatr Gastroenterol Nutr 1999, 29:612\u2013626.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"45_CR8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1067\/mpd.2001.117002","volume":"139","author":"DS Pashankar","year":"2001","unstructured":"Pashankar DS, Bishop WP: Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001, 139:428\u2013432.","journal-title":"J Pediatr"},{"key":"45_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1542\/peds.78.3.473","volume":"78","author":"S Rubinstein","year":"1986","unstructured":"Rubinstein S, Moss R, Lewiston N: Constipation and meconium ileus equivalent in patients with cystic fibrosis. Pediatrics 1986, 78:473\u2013479.","journal-title":"Pediatrics"},{"key":"45_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/000992289903800201","volume":"38","author":"C Siafakas","year":"1999","unstructured":"Siafakas C, Vottler TP, Andersen JM: Rectal prolapse in pediatrics. Clin Pediatr 1999, 38:63\u201372.","journal-title":"Clin Pediatr"},{"issue":"suppl 2","key":"45_CR11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-200100002-00001","volume":"32","author":"CD Rudolph","year":"2001","unstructured":"Rudolph CD: Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children. Recommendations of the North American Society for Pediatric Gastroenterology and Nutriiton. J Pediatr Gastroenterol Nutr 2001, 32(suppl 2):S1-S31.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"45_CR12","first-page":"1934","volume":"8","author":"E Hassall","year":"1993","unstructured":"Hassall E, Israel DM, Davidson AG, et al.: Barrett\u2019s esophagus in children with cystic fibrosis: not a coincidental association. Am J Gastroenterol 1993, 8:1934\u20131938.","journal-title":"Am J Gastroenterol"},{"key":"45_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1440-1754.1998.00159.x","volume":"34","author":"PJ Lewindon","year":"1998","unstructured":"Lewindon PJ, Robb TA, Moore DJ, et al.: Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health 1998, 34:79\u201382.","journal-title":"J Paediatr Child Health"},{"key":"45_CR14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199809033391001","volume":"339","author":"N Sharar","year":"1998","unstructured":"Sharar N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998, 339:645\u2013652.","journal-title":"N Engl J Med"},{"key":"45_CR15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/gast.2001.29673","volume":"121","author":"PG Noone","year":"2001","unstructured":"Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatic risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310\u20131319.","journal-title":"Gastroenterology"},{"key":"45_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","volume":"127","author":"DS Borowitz","year":"2001","unstructured":"Borowitz DS, Grand RJ, Durie PR, et al.: Use of pancreatic enzyme supplements with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 2001, 127:681\u2013684. This is the first and most comprehensive report from the CF Foundation with guidelines for pancreatic enzyme-replacement therapy and management.","journal-title":"J Pediatr"},{"key":"45_CR17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","volume":"336","author":"SC FitzSimmons","year":"1997","unstructured":"FitzSimmons SC, Burkhart GA, Borowitz D, et al.: Highdose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997, 336:1283\u20131289.","journal-title":"N Engl J Med"},{"key":"45_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11894-999-0040-4","volume":"1","author":"JD Lloyd-Still","year":"1999","unstructured":"Lloyd-Still JD, Beno DW, Kimura RM: Cystic fibrosing colonopathy. Curr Gastroenterol Rep 1999, 1:231\u2013237.","journal-title":"Curr Gastroenterol Rep"},{"key":"45_CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1155\/2001\/745361","volume":"15","author":"H Chaun","year":"2001","unstructured":"Chaun H: Colonic disorders in adult cystic fibrosis. Can J Gastroenterol 2001, 15:586\u2013590.","journal-title":"Can J Gastroenterol"},{"key":"45_CR20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","volume":"332","author":"J Neglia","year":"1995","unstructured":"Neglia J, FitzSimmons SC, Maisonneuve P, et al.: The risk of cancer among patients with cystic fibrosis. N Engl J Med 1995, 332:494\u2013499.","journal-title":"N Engl J Med"},{"key":"45_CR21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005176-200210003-00011","volume":"35","author":"RD Baker","year":"2002","unstructured":"Baker RD, Borowitz D, Stallings VA: Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002, 35:246\u2013259. This is a comprehensive summary of the nutritional aspects of the management in CF and provides the reader with some excellent information.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"45_CR22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.1552-4604.1994.tb03981.x","volume":"34","author":"M Kraisinger","year":"1994","unstructured":"Kraisinger M, Hochhaus G, Stecenko A, et al.: Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 1994, 34:158\u2013166.","journal-title":"J Clin Pharmacol"},{"key":"45_CR23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00006676-199710000-00003","volume":"15","author":"JH Meyer","year":"1997","unstructured":"Meyer JH, Lake R: Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres. Pancreas 1997, 15:226\u2013235.","journal-title":"Pancreas"},{"key":"45_CR24","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/jama.1990.03440180065033","volume":"263","author":"L Hendeles","year":"1990","unstructured":"Hendeles L, Dorf A, Stecenko A, et al.: Treatment failure after substitution of generic pancrelipase capsules. JAMA 1990, 263:2459\u20132461.","journal-title":"JAMA"},{"key":"45_CR25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gut.21.9.778","volume":"21","author":"PR Durie","year":"1980","unstructured":"Durie PR, Bell L, Linton W, et al.: Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 1980, 21:778\u2013786.","journal-title":"Gut"},{"key":"45_CR26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1651-2227.1998.tb01503.x","volume":"87","author":"TM Tran","year":"1998","unstructured":"Tran TM, Van den Neucker A, Hendriks JJ, et al.: Effects of a proton-pump inhibitor in cystic fibrosis. Acta Paediatr 1998, 87:553\u2013558.","journal-title":"Acta Paediatr"},{"key":"45_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/bega.2001.0195","volume":"15","author":"EP DiMagno","year":"2001","unstructured":"DiMagno EP: Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. Best Practice Res Clin Gastroenterol 2001, 15:477\u2013486.","journal-title":"Best Practice Res Clin Gastroenterol"},{"key":"45_CR28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/00005768-199906000-00003","volume":"31","author":"S Kreimler","year":"1999","unstructured":"Kreimler S, Wilk B, Schurer W, et al.: Preventing dehydration in children with cystic fibrosis who exercise in the heat. Med Sci Spots Exerc 1999, 31:774\u2013779.","journal-title":"Med Sci Spots Exerc"},{"key":"45_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1542\/peds.83.5.727","volume":"83","author":"S Koletzko","year":"1989","unstructured":"Koletzko S, Stringer DA, Cleghorn GJ, et al.: Lavage treatment of distal obstruction intestinal syndrome in children with cystic fibrosis. Pediatrics 1989, 83:727\u2013733.","journal-title":"Pediatrics"},{"key":"45_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/adc.76.1.35","volume":"76","author":"GJ Ellis","year":"1997","unstructured":"Ellis GJ, Dewar AL, Rolles CJ, et al.: Dietary fiber and the occurrence of gut symptoms in cystic fibrosis. Arch Dis Child 1997, 76:35\u201337.","journal-title":"Arch Dis Child"},{"key":"45_CR31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","volume":"28","author":"RJ Sokol","year":"1999","unstructured":"Sokol RJ, Durie PR, and the CF Foundation Hepatobiliary disease consensus group: Recommendations for the management of liver and biliary tract disease in cystic fibrosis. J Pediatr Gastenterol Nutr 1999, 28:S1-S13.","journal-title":"J Pediatr Gastenterol Nutr"},{"key":"45_CR32","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","volume":"23","author":"C Colombo","year":"1996","unstructured":"Colombo C, Battezzati PM, Podda M, et al.: Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian group for the study of ursodeoxycholic acid in cystic fibrosis. Hepatology 1996, 23:1484\u20131490.","journal-title":"Hepatology"},{"key":"45_CR33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","volume":"27","author":"A Lindblad","year":"1998","unstructured":"Lindblad A, Glaumann H, Strandvick B: A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 1998, 27:166\u2013174.","journal-title":"Hepatology"},{"key":"45_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005176-199801000-00009","volume":"26","author":"MR Narkewicz","year":"1998","unstructured":"Narkewicz MR, Smith D, Gregory C, et al.: Effect of ursodeoxyholic acid therapy on hepatic function in children with intrahepatic cholestasis. J Pediatr Gastro Nutr 1998, 26:49\u201355.","journal-title":"J Pediatr Gastro Nutr"},{"key":"45_CR35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"G Paumgartner","year":"2002","unstructured":"Paumgartner G: Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002, 36:525\u2013531.","journal-title":"Hepatology"},{"key":"45_CR36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.1840160412","volume":"16","author":"C Colombo","year":"1992","unstructured":"Colombo C, Crosgnani A, Assaisso M, et al.: Ursodeoxycholic therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology 1992, 16:924\u2013930.","journal-title":"Hepatology"},{"key":"45_CR37","first-page":"CD000222","volume":"2","author":"K Cheng","year":"2000","unstructured":"Cheng K, Ashby D, Smythe R: Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 2000, 2:CD000222.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"45_CR38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1651-2227.1993.tb12754.x","volume":"82","author":"C Colombo","year":"1993","unstructured":"Colombo C, Bertolini E, Assaisso ML, et al.: Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis. Acta Paeditr 1993, 82:562\u2013565.","journal-title":"Acta Paeditr"},{"key":"45_CR39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0676.1994.tb00004.x","volume":"14","author":"B Strandvick","year":"1994","unstructured":"Strandvick B, Hultcrantz R: Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis. Liver 1994, 14:32\u201336.","journal-title":"Liver"},{"key":"45_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","volume":"31","author":"D Debray","year":"1999","unstructured":"Debray D, Lykavieris P, Gauthier F, et al.: Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. J Hepatol 1999, 31:77\u201383.","journal-title":"J Hepatol"},{"key":"45_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00063198-200111000-00014","volume":"7","author":"YS Genyk","year":"2001","unstructured":"Genyk YS, Quiros JA, Jabbour N, et al.: Liver transplantation in cystic fibrosis. Curr Opin Pulmon Med 2001, 7:441\u2013447.","journal-title":"Curr Opin Pulmon Med"},{"key":"45_CR42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","volume":"30","author":"A Lindblad","year":"1999","unstructured":"Lindblad A, Glaumann H, Strandvik B: Natural history of liver disease in cystic fibrosis. Hepatology 1999, 30:1151\u20131158.","journal-title":"Hepatology"},{"key":"45_CR43","first-page":"340","volume":"2","author":"V Diwakar","year":"2001","unstructured":"Diwakar V, Pearson L, Beath S: Liver disease in children with cystic fibrosis. Paediatric Resp Rev 2001, 2:340\u2013349.","journal-title":"Paediatric Resp Rev"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0045-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-003-0045-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0045-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T22:02:13Z","timestamp":1737064933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-003-0045-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1007\/s11938-003-0045-2","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}